University of Rochester Honors Sabin Vaccine Institute’s Dr. Philip Russell
October 16, 2009
ROCHESTER, NY--The Sabin Vaccine Institute salutes its’ founding president, Major General Philip Russell, M.D., who will receive the 2009 Distinguished Alumni Award from the University of Rochester School of Medicine and Dentistry in Rochester, NY on October 16, 2009.
The annual award honors one alumnus who demonstrates a legacy of outstanding and widely recognized achievement in the field of medicine with particular emphasis on achievements that create a significant impact on a national or global scale.
“For more than three decades, Phil has served as a dynamic advocate for the development of vaccines that treat or prevent some of the world’s most devastating diseases,” said Dr. Peter Hotez, President of the Sabin Vaccine Institute. “Phil has a stellar record in the research and academic fields and the Sabin Vaccine Institute is proud that the University of Rochester is honoring such a deserving individual who truly exemplifies the qualities of a distinguished alumnus.”
After graduating from the UR School of Medicine and Dentistry in 1958, Dr. Russell began a career in infectious disease and tropical medicine research while serving in the US Army Medical Corps. Dr. Russell is professor emeritus at Johns Hopkins School of Hygiene and Public Health, Department of International Health and has authored over 100 publications on infectious disease. He has contributed to the successful development of several vaccines including adenovirus, meningitis, and hepatitis A and B. As director of the Walter Reed Army Institute of Research, he led research on vaccines against dengue and malaria.
Dr. Russell will present “Vaccines for the Developing World” to more than 100 alumni during the Distinguished Alumni Lecture on October 16. The Distinguished Alumni Award will be presented later that evening at the Alumni Awards Dinner.
About Sabin Vaccine Institute:
Sabin Vaccine Institute is a non-profit organization dedicated to reducing human suffering from infectious and neglected diseases. Through its efforts in vaccine research, development and advocacy, Sabin works to provide greater access to vaccines and essential medicines for millions stuck in pain, poverty and despair. Founded in 1993 in honor of Dr. Albert B. Sabin, discoverer of the oral polio vaccine, the Sabin Vaccine Institute works with prestigious institutions, scientists, medical professionals, and organizations to provide short and long-term solutions that result in healthier individuals, families and communities around the globe. For more information about Sabin’s research and commitment, visit: www.sabin.org.